IPUMS PMA: vars by letter: F

Person

FAMILY PLANNING Description	NUTRITION Description
CLIENT EXIT INTERVIEW Description	COVID-19 Description

Service Delivery Point

FAMILY PLANNING

Description

NUTRITION

Description

Infant

MATERNAL AND NEWBORN HEALTH

Description

Use this option if persons are the unit of analysis. Each record represents a household member, including resident women of childbearing age. Variables shown are based on either the household or female questionnaire.

Childbearing age is typically defined as ages 15-49.

Use this option if service delivery providers are the unit of analysis. Each record represents one facility, drawn from the same enumeration areas from which households were sampled.

Service delivery points include hospitals, health centers, clinics, pharmacies, and other facilities that might provide family planning services or products. The questionnaire was completed by a competent staff person at the facility.

Use this option if infants or women who have just given birth are the unit of analysis. Each record represents one infant.

These data are from a Maternal and Newborn Health survey, in which pregnant women are interviewed several times before and after delivery.

Use this option if persons are the unit of analysis. Each record represents a household member, including resident women between age 10 and 49, and young children. Variables shown are based on either the household or female questionnaire.

Use this option if service delivery providers are the unit of analysis. Each record represents one facility, drawn from the same enumeration areas from which households were sampled for the Nutrition surveys.

Service delivery points include hospitals, health centers, clinics, pharmacies, and other facilities that might provide nutrition programming or services. The questionnaire was completed by a competent staff person at the facility.

Use this option if women of childbearing age are the unit of analysis. Each record represents one woman who was interviewed as they were leaving a medical appointment at a surveyed service delivery point.

Use this option if women of childbearing age are the unit of analysis. Each record represents one woman who completed a phone interview about COVID-19.

An "X" indicates the variable is available for the listed sample.

Add to cart	Variable	Variable Label	Type	burkf 2014	burkf 2015	burkf 2016a	burkf 2016b	burkf 2017	burkf 2018	burkf 2020	burkf 2021	burkf 2022	burkf 2023	condr 2013	condr 2014	condr 2015a	condr 2015b	condr 2015c	condr 2016a	condr 2016b	condr 2017a	condr 2017b	condr 2018a	condr 2018b	condr 2019a	condr 2019b	condr 2020	condr 2020	Variable	condr 2021a	condr 2021b	condr 2024	cotedi 2017	cotedi 2018	cotedi 2020	cotedi 2020b	cotedi 2021	cotedi 2022	cotedi 2024	ethio 2014a	ethio 2014b	ethio 2015	ethio 2016	ethio 2017	ethio 2018	ethio 2019	ethio 2020	ethio 2021	ethio 2023	ghana 2013	ghana 2014a	ghana 2014b	ghana 2015	ghana 2016	Variable	ghana 2017	india 2016	india 2017a	india 2017b	india 2018	india 2020	india 2021	india 2022	indon 2015	indon 2016	kenya 2014a	kenya 2014b	kenya 2015a	kenya 2015b	kenya 2016	kenya 2017	kenya 2018	kenya 2019	kenya 2020	kenya 2021	niger 2015	niger 2016a	niger 2016b	niger 2017	niger 2018	Variable	niger 2020	niger 2022	niger 2023a	niger 2023b	nigera 2014a	nigera 2014b	nigera 2015a	nigera 2015b	nigera 2016	nigera 2017a	nigera 2017b	nigera 2018	nigera 2019a	nigera 2019b	nigera 2019c	nigera 2020a	nigera 2020b	nigera 2021a	nigera 2021b	nigera 2023a	nigera 2023b	ugand 2014	ugand 2015a	ugand 2015b	ugand 2016	Variable	ugand 2017	ugand 2018	ugand 2019	ugand 2020	ugand 2021	ugand 2022
F (Group continued on next page...) [top]
Add to cart	Variable	Variable Label	Type	BF 14	BF 15	BF 16a	BF 16b	BF 17	BF 18	BF 20	BF 21	BF 22	BF 23	CD 13	CD 14	CD 15a	CD 15b	CD 15c	CD 16a	CD 16b	CD 17a	CD 17b	CD 18a	CD 18b	CD 19a	CD 19b	CD 20	CD 20	Variable	CD 21a	CD 21b	CD 24	CI 17	CI 18	CI 20	CI 20b	CI 21	CI 22	CI 24	ET 14a	ET 14b	ET 15	ET 16	ET 17	ET 18	ET 19	ET 20	ET 21	ET 23	GH 13	GH 14a	GH 14b	GH 15	GH 16	Variable	GH 17	IN 16	IN 17a	IN 17b	IN 18	IN 20	IN 21	IN 22	ID 15	ID 16	KE 14a	KE 14b	KE 15a	KE 15b	KE 16	KE 17	KE 18	KE 19	KE 20	KE 21	NE 15	NE 16a	NE 16b	NE 17	NE 18	Variable	NE 20	NE 22	NE 23a	NE 23b	NG 14a	NG 14b	NG 15a	NG 15b	NG 16	NG 17a	NG 17b	NG 18	NG 19a	NG 19b	NG 19c	NG 20a	NG 20b	NG 21a	NG 21b	NG 23a	NG 23b	UG 14	UG 15a	UG 15b	UG 16	Variable	UG 17	UG 18	UG 19	UG 20	UG 21	UG 22
	FPSERECPLEAS	Side effect experienced recently: decreased sexual pleasure	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPLEAS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSERECPLEAS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPLEAS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPLEAS	.	.	.	.	.	.
	FPSERECPTR	Side effect experienced recently: partner feels during sex	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPTR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSERECPTR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPTR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPTR	.	.	.	.	.	.
	FPSERECUTCRAMP	Side effect experienced recently: uterine cramping/lower abdominal pain	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSERECUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECUTCRAMP	.	.	.	.	.	.
	FPSERECWEAK	Side effect experienced recently: general weakness/pain	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSERECWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWEAK	.	.	.	.	.	.
	FPSERECWTGAIN	Side effect experienced recently: gained weight	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSERECWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTGAIN	.	.	.	.	.	.
	FPSERECWTLOSS	Side effect experienced recently: lost weight	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSERECWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTLOSS	.	.	.	.	.	.
	FPSERHY	Method used when having side effects: rhythm	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERHY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERHY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERHY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERHY	.	X	.	.	.	.
	FPSESPOT	Side effect experienced: spotting	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSESPOT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSESPOT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSESPOT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSESPOT	.	X	.	.	.	.
	FPSESWITCH	Told if have side effects can switch FP	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSESWITCH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	FPSESWITCH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSESWITCH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSESWITCH	.	X	.	.	.	.
	FPSETALKCUR	Discussed side effects with anyone (current method)	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKCUR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	X	.	.	.	.	.	FPSETALKCUR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKCUR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKCUR	.	.	X	.	.	.
	FPSETALKPREV	Discussed side effects with anyone (method before recent)	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKPREV	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKPREV	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKPREV	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKPREV	.	.	X	.	.	.
	FPSETALKREC	Discussed side effects with anyone (most recent method)	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKREC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKREC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKREC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKREC	.	.	X	.	.	.
	FPSEUTCRAMP	Side effect experienced: uterine cramping	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEUTCRAMP	.	X	.	.	.	.
	FPSEWEAK	Side effect experienced: weakness	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWEAK	.	X	.	.	.	.
	FPSEWITH	Method used when having side effects: withdrawal	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWITH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWITH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWITH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWITH	.	X	.	.	.	.
	FPSEWTGAIN	Side effect experienced: weight gain	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWTGAIN	.	X	.	.	.	.
	FPSEWTLOSS	Side effect experienced: weight loss	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWTLOSS	.	X	.	.	.	.
	FPSIDEEFFECTEV	Ever had side effects from FP	P	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSIDEEFFECTEV	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSIDEEFFECTEV	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSIDEEFFECTEV	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSIDEEFFECTEV	.	X	.	.	.	.
	FPSOCMEDIA	Seen about FP on social media in last few months	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSOCMEDIA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	X	X	.	.	.	.	.	FPSOCMEDIA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSOCMEDIA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSOCMEDIA	.	.	X	.	.	.
	FPSTARTWHEN	When might start using FP method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTARTWHEN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTARTWHEN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTARTWHEN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTARTWHEN	.	X	X	.	.	.
F (continued) (Group continued on next page...) [top]
Add to cart	Variable	Variable Label	Type	burkf 2014	burkf 2015	burkf 2016a	burkf 2016b	burkf 2017	burkf 2018	burkf 2020	burkf 2021	burkf 2022	burkf 2023	condr 2013	condr 2014	condr 2015a	condr 2015b	condr 2015c	condr 2016a	condr 2016b	condr 2017a	condr 2017b	condr 2018a	condr 2018b	condr 2019a	condr 2019b	condr 2020	condr 2020	Variable	condr 2021a	condr 2021b	condr 2024	cotedi 2017	cotedi 2018	cotedi 2020	cotedi 2020b	cotedi 2021	cotedi 2022	cotedi 2024	ethio 2014a	ethio 2014b	ethio 2015	ethio 2016	ethio 2017	ethio 2018	ethio 2019	ethio 2020	ethio 2021	ethio 2023	ghana 2013	ghana 2014a	ghana 2014b	ghana 2015	ghana 2016	Variable	ghana 2017	india 2016	india 2017a	india 2017b	india 2018	india 2020	india 2021	india 2022	indon 2015	indon 2016	kenya 2014a	kenya 2014b	kenya 2015a	kenya 2015b	kenya 2016	kenya 2017	kenya 2018	kenya 2019	kenya 2020	kenya 2021	niger 2015	niger 2016a	niger 2016b	niger 2017	niger 2018	Variable	niger 2020	niger 2022	niger 2023a	niger 2023b	nigera 2014a	nigera 2014b	nigera 2015a	nigera 2015b	nigera 2016	nigera 2017a	nigera 2017b	nigera 2018	nigera 2019a	nigera 2019b	nigera 2019c	nigera 2020a	nigera 2020b	nigera 2021a	nigera 2021b	nigera 2023a	nigera 2023b	ugand 2014	ugand 2015a	ugand 2015b	ugand 2016	Variable	ugand 2017	ugand 2018	ugand 2019	ugand 2020	ugand 2021	ugand 2022
Add to cart	Variable	Variable Label	Type	BF 14	BF 15	BF 16a	BF 16b	BF 17	BF 18	BF 20	BF 21	BF 22	BF 23	CD 13	CD 14	CD 15a	CD 15b	CD 15c	CD 16a	CD 16b	CD 17a	CD 17b	CD 18a	CD 18b	CD 19a	CD 19b	CD 20	CD 20	Variable	CD 21a	CD 21b	CD 24	CI 17	CI 18	CI 20	CI 20b	CI 21	CI 22	CI 24	ET 14a	ET 14b	ET 15	ET 16	ET 17	ET 18	ET 19	ET 20	ET 21	ET 23	GH 13	GH 14a	GH 14b	GH 15	GH 16	Variable	GH 17	IN 16	IN 17a	IN 17b	IN 18	IN 20	IN 21	IN 22	ID 15	ID 16	KE 14a	KE 14b	KE 15a	KE 15b	KE 16	KE 17	KE 18	KE 19	KE 20	KE 21	NE 15	NE 16a	NE 16b	NE 17	NE 18	Variable	NE 20	NE 22	NE 23a	NE 23b	NG 14a	NG 14b	NG 15a	NG 15b	NG 16	NG 17a	NG 17b	NG 18	NG 19a	NG 19b	NG 19c	NG 20a	NG 20b	NG 21a	NG 21b	NG 23a	NG 23b	UG 14	UG 15a	UG 15b	UG 16	Variable	UG 17	UG 18	UG 19	UG 20	UG 21	UG 22
	FPSTERNOCH	Told sterilization would mean no more children	P	X	X	X	X	X	.	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	FPSTERNOCH	X	X	X	X	.	.	.	X	X	X	X	X	X	X	X	X	X	.	X	X	X	X	X	X	X	FPSTERNOCH	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	.	FPSTERNOCH	.	X	X	X	X	.	X	X	X	X	X	X	X	X	.	X	X	X	X	X	X	X	X	X	X	FPSTERNOCH	X	X	X	.	X	X
	FPSTOPMO	Month stopped using most recent method	P	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	FPSTOPMO	X	X	X	X	X	X	.	X	.	X	X	X	X	X	X	X	.	.	.	.	X	X	X	X	X	FPSTOPMO	X	X	X	X	X	.	X	.	X	X	X	X	X	X	X	X	X	.	.	X	X	X	X	X	X	FPSTOPMO	X	X	.	X	X	X	X	X	X	X	X	X	X	X	.	X	X	X	X	X	X	X	X	X	X	FPSTOPMO	X	X	.	.	X	.
	FPSTOPMO1	Month stopped using most recent FP method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPMO1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO1	.	.	X	.	.	.
	FPSTOPMO1DQ	Respondent does not know month stopped using most recent method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO1DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPMO1DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO1DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO1DQ	.	.	.	.	.	.
	FPSTOPMO2	Month stopped using second most recent FP method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPMO2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO2	.	.	X	.	.	.
	FPSTOPMO2DQ	Respondent does not know month stopped using second most recent method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO2DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPMO2DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO2DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO2DQ	.	.	.	.	.	.
	FPSTOPMO3	Month stopped using third most recent FP method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPMO3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO3	.	.	X	.	.	.
	FPSTOPMO3DQ	Respondent does not know month stopped using third most recent method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO3DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPMO3DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO3DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO3DQ	.	.	.	.	.	.
	FPSTOPMO4	Month stopped using fourth most recent FP method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPMO4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO4	.	.	.	.	.	.
	FPSTOPMO4DQ	Respondent does not know month stopped using fourth most recent method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO4DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPMO4DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO4DQ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPMO4DQ	.	.	.	.	.	.
	FPSTOPUSECMC	Date stopped using recent method of FP in century month	P	X	X	X	X	X	X	X	X	.	.	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	FPSTOPUSECMC	.	.	.	X	X	X	.	.	.	.	X	X	X	X	X	X	.	.	.	.	X	X	X	X	X	FPSTOPUSECMC	X	X	X	X	X	.	.	.	X	X	X	X	X	X	X	X	X	.	.	.	X	X	X	X	X	FPSTOPUSECMC	.	.	.	.	X	X	X	X	X	X	X	X	X	X	.	X	X	.	.	.	.	X	X	X	X	FPSTOPUSECMC	X	X	.	.	.	.
	FPSTOPWHY	Reason stopped using FP	P	X	X	X	X	.	.	.	.	.	.	X	X	X	X	X	X	X	X	X	.	.	.	.	.	.	FPSTOPWHY	.	.	.	X	.	.	.	.	.	.	X	X	X	X	X	.	.	.	.	.	X	X	X	X	X	FPSTOPWHY	X	X	X	X	.	.	.	.	X	X	X	X	X	X	X	.	.	.	.	.	X	X	X	X	.	FPSTOPWHY	.	.	.	.	X	X	X	X	X	X	.	.	.	.	.	.	.	.	.	.	.	X	X	X	X	FPSTOPWHY	X	.	.	.	.	.
	FPSTOPYR	Year stopped using most recent method	P	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	FPSTOPYR	X	X	X	X	X	X	.	X	.	X	X	X	X	X	X	X	.	.	.	.	X	X	X	X	X	FPSTOPYR	X	X	X	X	X	.	X	.	X	X	X	X	X	X	X	X	X	.	.	X	X	X	X	X	X	FPSTOPYR	X	X	.	X	X	X	X	X	X	X	X	X	X	X	.	X	X	X	X	X	X	X	X	X	X	FPSTOPYR	X	X	.	.	X	.
	FPSTOPYR1	Year stopped using most recent FP method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPYR1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR1	.	.	X	.	.	.
	FPSTOPYR2	Year stopped using second most recent FP method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPYR2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR2	.	.	X	.	.	.
	FPSTOPYR3	Year stopped using third most recent FP method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPYR3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR3	.	.	X	.	.	.
	FPSTOPYR4	Year stopped using fourth most recent FP method	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPSTOPYR4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSTOPYR4	.	.	.	.	.	.
	FPSUPPHEALTH	Using family planning preserves a woman's health (self)	P	.	.	.	.	.	.	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	.	.	X	X	FPSUPPHEALTH	X	X	X	.	.	.	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSUPPHEALTH	.	.	.	.	.	.	X	X	.	.	.	.	.	.	.	.	.	.	X	X	.	.	.	.	.	FPSUPPHEALTH	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	X	X	X	X	X	X	.	.	.	.	FPSUPPHEALTH	.	.	.	.	X	X
	FPSUPPHEALTHCOMM	Using family planning preserves a woman's health (community)	P	.	.	.	.	.	.	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	.	.	X	X	FPSUPPHEALTHCOMM	X	X	X	.	.	.	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSUPPHEALTHCOMM	.	.	.	.	.	.	X	X	.	.	.	.	.	.	.	.	.	.	X	X	.	.	.	.	.	FPSUPPHEALTHCOMM	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	X	X	X	X	X	X	.	.	.	.	FPSUPPHEALTHCOMM	.	.	.	.	X	X
	FPSUPPSCHOOL	Women using family planning can support children's schooling (self)	P	.	.	.	.	.	.	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	.	.	X	X	FPSUPPSCHOOL	X	X	X	.	.	.	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSUPPSCHOOL	.	.	.	.	.	.	X	X	.	.	.	.	.	.	.	.	.	.	X	X	.	.	.	.	.	FPSUPPSCHOOL	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	X	X	X	X	X	X	.	.	.	.	FPSUPPSCHOOL	.	.	.	.	X	X
F (continued) (Group continued on next page...) [top]
Add to cart	Variable	Variable Label	Type	burkf 2014	burkf 2015	burkf 2016a	burkf 2016b	burkf 2017	burkf 2018	burkf 2020	burkf 2021	burkf 2022	burkf 2023	condr 2013	condr 2014	condr 2015a	condr 2015b	condr 2015c	condr 2016a	condr 2016b	condr 2017a	condr 2017b	condr 2018a	condr 2018b	condr 2019a	condr 2019b	condr 2020	condr 2020	Variable	condr 2021a	condr 2021b	condr 2024	cotedi 2017	cotedi 2018	cotedi 2020	cotedi 2020b	cotedi 2021	cotedi 2022	cotedi 2024	ethio 2014a	ethio 2014b	ethio 2015	ethio 2016	ethio 2017	ethio 2018	ethio 2019	ethio 2020	ethio 2021	ethio 2023	ghana 2013	ghana 2014a	ghana 2014b	ghana 2015	ghana 2016	Variable	ghana 2017	india 2016	india 2017a	india 2017b	india 2018	india 2020	india 2021	india 2022	indon 2015	indon 2016	kenya 2014a	kenya 2014b	kenya 2015a	kenya 2015b	kenya 2016	kenya 2017	kenya 2018	kenya 2019	kenya 2020	kenya 2021	niger 2015	niger 2016a	niger 2016b	niger 2017	niger 2018	Variable	niger 2020	niger 2022	niger 2023a	niger 2023b	nigera 2014a	nigera 2014b	nigera 2015a	nigera 2015b	nigera 2016	nigera 2017a	nigera 2017b	nigera 2018	nigera 2019a	nigera 2019b	nigera 2019c	nigera 2020a	nigera 2020b	nigera 2021a	nigera 2021b	nigera 2023a	nigera 2023b	ugand 2014	ugand 2015a	ugand 2015b	ugand 2016	Variable	ugand 2017	ugand 2018	ugand 2019	ugand 2020	ugand 2021	ugand 2022
Add to cart	Variable	Variable Label	Type	BF 14	BF 15	BF 16a	BF 16b	BF 17	BF 18	BF 20	BF 21	BF 22	BF 23	CD 13	CD 14	CD 15a	CD 15b	CD 15c	CD 16a	CD 16b	CD 17a	CD 17b	CD 18a	CD 18b	CD 19a	CD 19b	CD 20	CD 20	Variable	CD 21a	CD 21b	CD 24	CI 17	CI 18	CI 20	CI 20b	CI 21	CI 22	CI 24	ET 14a	ET 14b	ET 15	ET 16	ET 17	ET 18	ET 19	ET 20	ET 21	ET 23	GH 13	GH 14a	GH 14b	GH 15	GH 16	Variable	GH 17	IN 16	IN 17a	IN 17b	IN 18	IN 20	IN 21	IN 22	ID 15	ID 16	KE 14a	KE 14b	KE 15a	KE 15b	KE 16	KE 17	KE 18	KE 19	KE 20	KE 21	NE 15	NE 16a	NE 16b	NE 17	NE 18	Variable	NE 20	NE 22	NE 23a	NE 23b	NG 14a	NG 14b	NG 15a	NG 15b	NG 16	NG 17a	NG 17b	NG 18	NG 19a	NG 19b	NG 19c	NG 20a	NG 20b	NG 21a	NG 21b	NG 23a	NG 23b	UG 14	UG 15a	UG 15b	UG 16	Variable	UG 17	UG 18	UG 19	UG 20	UG 21	UG 22
	FPSUPPSCHOOLCOMM	Women using family planning can support children's schooling (community)	P	.	.	.	.	.	.	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	.	.	X	X	FPSUPPSCHOOLCOMM	X	X	X	.	.	.	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSUPPSCHOOLCOMM	.	.	.	.	.	.	X	X	.	.	.	.	.	.	.	.	.	.	X	X	.	.	.	.	.	FPSUPPSCHOOLCOMM	.	X	X	X	.	.	.	.	.	.	.	.	.	.	.	X	X	X	X	X	X	.	.	.	.	FPSUPPSCHOOLCOMM	.	.	.	.	X	X
	FPTALKHUS	Talked with husband/partner about using a contraceptive method	P	.	.	.	X	X	X	X	X	X	X	.	.	.	.	.	X	X	X	X	X	X	X	X	X	X	FPTALKHUS	X	X	X	X	X	X	.	X	X	X	.	.	.	.	X	X	X	.	X	X	.	.	.	.	X	FPTALKHUS	X	.	X	X	X	X	X	X	.	X	.	.	.	.	X	X	X	X	X	X	.	.	X	X	X	FPTALKHUS	X	X	X	X	.	.	.	.	.	X	X	X	X	X	.	X	X	X	X	X	X	.	.	.	.	FPTALKHUS	X	X	X	X	X	.
	FPTEACHINFO	Obtained FP info from: teacher	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTEACHINFO	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTEACHINFO	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTEACHINFO	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTEACHINFO	.	.	.	.	.	.
	FPTELLOPTIONS	Thinks healthcare providers should inform about different FP options	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTELLOPTIONS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	FPTELLOPTIONS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTELLOPTIONS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTELLOPTIONS	.	.	.	.	.	.
	FPTOLDBEADS	Methods discussed with provider: standard days/cycle beads	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDBEADS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDBEADS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDBEADS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDBEADS	.	.	.	.	.	.
	FPTOLDDIA	Methods discussed with provider: diaphragm	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDDIA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDDIA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDDIA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDDIA	.	.	.	.	.	.
	FPTOLDEC	Methods discussed with provider: emergency contraception	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDEC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDEC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDEC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDEC	.	.	.	.	.	.
	FPTOLDFC	Methods discussed with provider: female condoms	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDFC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFC	.	.	.	.	.	.
	FPTOLDFJ	Methods discussed with provider: foam/jelly	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFJ	.	.	.	.	.	.
	FPTOLDFRND2	How knew that Friend 2 uses IUD or implant	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFRND2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	FPTOLDFRND2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFRND2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFRND2	.	.	.	.	.	.
	FPTOLDFRND3	Friend 3: How respondent knew friend uses an IUD or implant	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFRND3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	FPTOLDFRND3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFRND3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFRND3	.	.	.	.	.	.
	FPTOLDFSTER	Methods discussed with provider: female sterilization	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDFSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDFSTER	.	.	.	.	.	.
	FPTOLDIMP	Methods discussed with provider: implants	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDIMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDIMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDIMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDIMP	.	.	.	.	.	.
	FPTOLDINJ	Methods discussed with provider: injectables	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDINJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDINJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDINJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDINJ	.	.	.	.	.	.
	FPTOLDIUD	Methods discussed with provider: IUDs	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDIUD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDIUD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDIUD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDIUD	.	.	.	.	.	.
	FPTOLDLAM	Methods discussed with provider: breastfeeding as a family planning method	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDLAM	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDLAM	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDLAM	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDLAM	.	.	.	.	.	.
	FPTOLDMCON	Methods discussed with provider: male condoms	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDMCON	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDMCON	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDMCON	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDMCON	.	.	.	.	.	.
	FPTOLDMSTER	Methods discussed with provider: male sterilization	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDMSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDMSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDMSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDMSTER	.	.	.	.	.	.
	FPTOLDOTHTRAD	Methods discussed with provider: other traditional	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDOTHTRAD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDOTHTRAD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDOTHTRAD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDOTHTRAD	.	.	.	.	.	.
	FPTOLDPILL	Methods discussed with provider: the pill	P	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDPILL	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	FPTOLDPILL	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDPILL	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPTOLDPILL	.	.	.	.	.	.

bf	Burkina Faso	burkf
cd	Congo (Democratic Republic)	condr
ci	Cote d'Ivoire	cotedi
et	Ethiopia	ethio
gh	Ghana	ghana
in	India	india
id	Indonesia	indon
ke	Kenya	kenya
ne	Niger	niger
ng	Nigeria	nigera
ug	Uganda	ugand

Data Cart

Your data extract

0	variables
0	samples